Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 11, Number 1—January 2005

Research

Border Screening for SARS

Ronald K. St. John*, Arlene King*, Dick de Jong*, Margaret Bodie-Collins*, Susan G. Squires*, and Theresa WS Tam*
Author affiliations: *Public Health Agency, Ottawa, Ontario, Canada

Main Article

Table 3

Travel histories of persons departing from Canada in whom a SARS-like illness was subsequently diagnosed*

Case no. Age Sex Depart date, Toronto Onset of illness Probable 
SARS† Link‡ Remarks
1 3 F March 28 March 31 Yes No PCR negative for SARS-CoV
2 5 M March 28 March 25 Yes No No evidence of pneumonia, 
PCR negative for SARS-CoV
3 1 M March 28 April 1 Yes No No evidence of pneumonia, 
PCR negative for SARS-CoV
4 26 F March 31 April 3 Yes No PCR and serologic test results 
negative for SAR-CoV
5 52 M April 1 April 3 Yes Yes Traveled by car, PCR and serologic test results positive for SARS-CoV
6 46 F April 3 April 6 Yes Yes Fatal SARS case
7 24 M April 28 April 30 Yes No Serologic and PCR test results 
negative for SARS-CoV
8 28 F April 24 May 3 Yes No No laboratory results available
9 29 M May 10 May 13 Yes No Traveled by car, PCR negative and acute serologic test results negative for SARS-CoV (convalescent-phase serologic test results not available)
10 47 M May 17 May 24 Yes Yes Acute–phase serologic test results 
positive for SARS-CoV
11 25 M July 14 July 7 Yes No Laboratory results unavailable

*SARS, severe acute respiratory syndrome; F, female; M. male; SARS-CoV, SARS-associated coronavirus; PCR, polymerase chain reaction.
†Met the World Health Organization probable SARS case definition at time of illness.
‡Is an epidemiologic link to another SARS case established?

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO